NasdaqCM - Nasdaq Real Time Price USD

Immix Biopharma, Inc. (IMMX)

1.7100
0.0000
(0.00%)
As of 12:54:15 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
22,674.6800
22,674.6800
16,141.1130
8,218.9480
1,352.0140
Operating Income
-22,674.6800
-22,674.6800
-16,141.1130
-8,218.9480
-1,352.0140
Net Non Operating Interest Income Expense
1,017.3540
1,017.3540
572.0060
-0.4970
-179.8530
Other Income Expense
--
--
--
--
-22,845.9990
Pretax Income
-21,657.3260
-21,657.3260
-15,569.1070
-8,219.4450
-24,377.8660
Tax Provision
41.0370
41.0370
26.4150
10.2680
6.0130
Net Income Common Stockholders
-21,613.3760
-21,613.3760
-15,426.0480
-8,229.7130
-24,383.8790
Diluted NI Available to Com Stockholders
-21,613.3760
-21,613.3760
-15,426.0480
-8,229.7130
-24,383.8790
Basic EPS
-0.76
--
-0.89
-0.59
-6.64
Diluted EPS
-0.76
--
-0.89
-0.59
-6.64
Basic Average Shares
28,285.6370
--
17,341.1460
13,887.3090
3,672.6110
Diluted Average Shares
28,285.6370
--
17,341.1460
13,887.3090
3,672.6110
Total Operating Income as Reported
-22,674.6800
-22,674.6800
-16,141.1130
-8,218.9480
-1,352.0140
Total Expenses
22,674.6800
22,674.6800
16,141.1130
8,218.9480
1,352.0140
Net Income from Continuing & Discontinued Operation
-21,613.3760
-21,613.3760
-15,426.0480
-8,229.7130
-24,383.8790
Normalized Income
-21,613.3760
-21,613.3760
-15,426.0480
-8,229.7130
-7,706.2997
Interest Income
1,017.3540
1,017.3540
572.0060
--
--
Interest Expense
--
--
--
0.4970
179.8530
Net Interest Income
1,017.3540
1,017.3540
572.0060
-0.4970
-179.8530
EBIT
-22,674.6800
-22,674.6800
-16,141.1130
-8,218.9480
-24,198.0130
EBITDA
-22,559.2920
-22,559.2920
-16,135.6450
-8,216.8130
-24,195.5450
Reconciled Depreciation
115.3880
115.3880
5.4680
2.1350
2.4680
Net Income from Continuing Operation Net Minority Interest
-21,613.3760
-21,613.3760
-15,426.0480
-8,229.7130
-24,383.8790
Total Unusual Items Excluding Goodwill
--
--
--
--
-22,845.9990
Total Unusual Items
--
--
--
--
-22,845.9990
Normalized EBITDA
-22,559.2920
-22,559.2920
-16,135.6450
-8,216.8130
-1,349.5460
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
--
--
--
--
-6,168.4197
12/31/2021 - 12/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KTTA Pasithea Therapeutics Corp.
1.5550
+0.97%
 
OLMA Olema Pharmaceuticals, Inc.
5.11
+3.02%
 
ENSC Ensysce Biosciences, Inc.
3.4150
+82.62%
 
A71.F Ascendis Pharma A/S
142.00
+1.43%
 
LTI0.F Aptose Biosciences Inc. R
2.0200
+1.00%
 
IVBXF Innovent Biologics, Inc.
5.98
0.00%
 
APTOF Aptose Biosciences Inc.
2.4700
0.00%
 
BINV.ST BioInvent International AB (publ)
29.10
+3.19%
 
CLVLY Clinuvel Pharmaceuticals Limited
7.10
0.00%
 
PDSB PDS Biotechnology Corporation
1.2200
+6.09%